We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Exempts Phase I Drugs From GMPs, Issues Guidance for INDs
FDA Exempts Phase I Drugs From GMPs, Issues Guidance for INDs
July 18, 2008
More than two years after withdrawing a final rule that would have exempted investigational drugs in Phase I testing from certain good manufacturing practice (GMP) regulations, the FDA is issuing a final rule to do just that.